IKOP Pharma Wins The BrandLaureate Awards 2026, Strengthening IIUM Holdings’ Position in the Pharmaceutical Industry
KUALA LUMPUR, 29 April 2026 – The IIUM Holdings Sdn Bhd Group celebrates another significant milestone as its subsidiary, IKOP Pharma, received the prestigious The BrandLaureate Awards 2026.
The award ceremony, held on Wednesday at The Majestic Hotel, Kuala Lumpur, recognised IKOP Pharma in the Manufacturing OEM Pharmaceutical Solution category.
Commitment to Halal Pharmaceutical Standards
This international recognition reflects the Group’s continued commitment to advancing the highest standards in Malaysia’s Halal pharmaceutical industry. As a key player in pharmaceutical manufacturing, IKOP Pharma ensures that every OEM solution it delivers meets global quality standards while upholding Shariah integrity.
The achievement not only demonstrates operational excellence but also reflects the dedication and collective efforts of the entire workforce across the IIUM Holdings Group.
Advancing the #RISE2030 Vision and IIUM Holdings’ Silver Jubilee
This achievement comes at a meaningful time as IIUM Holdings celebrates its 25th anniversary, marking its Silver Jubilee. The recognition further strengthens the Group’s commitment to achieving its #RISE2030 vision.
Through this vision, IIUM Holdings is committed to:
- Driving continuous innovation in the healthcare sector.
- Delivering greater value to the community through safe and trusted pharmaceutical products.
- Strengthening the national economy by advancing the local Halal industry.
Congratulations to Team IKOP Pharma
The IIUM Holdings management extends its heartfelt congratulations to the entire IKOP Pharma team. Your dedication has contributed to the company’s continued pursuit of excellence. May this recognition from The BrandLaureate inspire the team to continue reaching greater heights and making a positive contribution to the nation.